# 

# 



## 

## 

|Trustees||Professor lan Gumming|Professor lan Gumming|(Chair)|(Chair)|||
|---|---|---|---|---|---|---|---|
|||Mrs Wendy Farrlngton-Chadd|||(Non-|||
|||Executive Director)||||||
|||Mrs Narinder<br>Kooner (Non-Executive||||||
|||Director)||||||
|||Mr M Khan (Non-Execulve|||Director)|||
|||Mr M Fessal (Non-Executive|||Director)|||
|||Mrs 5Bayliss-Pratt|(Non-Execugve|||(Appointed|1April 2021)|
|||Director)||||||
|||Professor Anthony|Marsh (Chief|||||
|||Executive)||||||
|||Dr AWalker (Medical Director)||||||
|||Mr Mark Docherty|(Director||of|||
|||Nursing,<br>Quality and Clinical)||||||
|||Mr PJarvis||||(Appointed|15August|
|||||||2022)||
|Charity number||1058359||||||
|Principal address||Millennium<br>Point||||||
|||Waterfront<br>Business Park||||||
|||Waterfront<br>Way||||||
|||Brierley<br>Hill||||||
|||West Midlands||||||
|||United<br>Kingdom||||||
|||DY5 tLX||||||
|Independent|examiner|Azets Audil Services||||||
|||1st Floor||||||
|||Copthall House||||||
|||1 New Road||||||
|||Btourbridge||||||
|||West Midlands||||||
|||United<br>Kingdom||||||
|||DY8 1PH||||||
|Bankers||Royal Bank ofScotland||Pic||||
|||Government<br>Bnkg|Serv|Branch||||
|||EC2M 4BA||||||
|Solicitors||Mills and Reeve||||||
|||54 Hagley Road||||||
|||Edgbaston||||||
|||Birmingham||||||
|||B16BPE||||||





## 



## 

## 

||||Page|
|---|---|---|---|
|Trustees<br>report|||f-4|
|Independent<br>examiner's||report||
|Statement of financial|activities|||
|Balance sheet||||
|Statement ofcash flows||||
|Notes to the financial|statements||9-18|





## 

## 

## 



## 

## 

## 

|Summary|ofIncome 6Expenditure|2021-22|2020-21|
|---|---|---|---|
|||6000|6000|
|Totallncome|||216|
|otal Expenditure||(503)|(140)|
|Net (incoming) before transfers|||76|
|Cash fund|balances at 1 April||172|
|Cash fund|balances at 31March|293||
|Statement|ofAssets ft LiabiINas|31March 2022|31 March 2021|
|||2000|EOOO|
||||272|
|Investment|Assets|||
|i.iabilities||(315)|(26)|





## 

## 

## 



## 

## 




## 

## 

## 

## 

## 



## 

## 

||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|---|
||||funds|funds||funds|funds||
||||2022|2022|2022|2021|2021|2021|
|||Notes|6||f||8|8|
|Lnggm! frgrm!|||||||||
|Donations and|legacies|3|15,054|532,764|547,818|36,880|179,800|216,480|
|Investments||4|328||328|35||35|
|Total income|||15,382|532,764|548.146|36,915|179,600|216,515|
|gzpy tttl(Igr~o<br>Ghad!table activities||5|112,312|390,422|502.734|56,154|83,918|140,072|
|Net (expenditure)/income|||||||||
|forthe year/|||||||||
|Net movement|in funds||(98,930)|142,342|45,412|(19,239)|95,682|76,443|
|Fund balances|a( 1April|2021|152,779|95,682|248,461|172.018||172,018|
|Fund balances|at 31 Nlarch||||||||
|2022|||55,849|238,024|293.873|152,779|95,682|248,461|





## 

## 

## 




## 

## 

## 

||||||2022||2021||
|---|---|---|---|---|---|---|---|---|
|||||Notes|||||
|Cash flows from operating|||activities||||||
|Cash generated||from operations||15||331,363||100,233|
|Investing|activities||||||||
|Investment|income received||||328||35||
|Net cash|generated<br>from investing||||||||
|activities||||||328||35|
|Net cash|used|in financing|activities||||||
|Net increase in||cash and cash equivalents||||331,691||100,268|
|Cash and|cash|equivalents|al beginning|ofyear||272,607||172,339|
|Cash and|cash|equivalents|at end of|year||604,298||272,607|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 




## 

## 

|4|Investments|Investments|||||
|---|---|---|---|---|---|---|
||||||Unrestricted|Unrestricted|
||||||funds|funds|
||||||2022|2021|
||||||6|f.|
||Investment||income||328|35|
|5|Chart table activities||||||
||||||Total|Total|
||||||2022|2021|
||||||6||
||Staff welfare||||182,469|138,170|
||Patients welfare and|||amenities|309,589||
||||||492,058|136,170|
||Share ofsupport costs (see note 6)||||7,940|2,462|
||Share ofgovernance|||costs (see note 6)|2,736|1,440|
||||||502,734|140,072|
||Analysis|by fund|||||
||Unrestricted||funds||112,312|56,154|
||Restricted|funds|||390.422|83,918|
||||||502,734|140,072|





## 

## 


## 

## 

## 

## 




## 

## 

## 

|0|Current|asset inves|tments|||
|---|---|---|---|---|---|
|||||2022|2021|
|||||6||
||Unlisted|invesimenis||4,248|4,246|
|10|Creditors: amounts||failing due within one year|||
|||||2022|2021|
|||||6||
||Other creditors|||314,673|28,392|





## 

## 

## 

||||Nlovement|in funds||tftovement|in funds|||
|---|---|---|---|---|---|---|---|---|---|
|||||Resouroes|aalanoe el||Resources||aalenee al|
||||f|ascended<br>8|1April2021<br>8|8|earrended<br>f|01|rdaroh 2022<br>8|
|NHS|Charities|Covid 'l9|77,500|(27,297)|50,202||(34,056)||16,147|
|NHS|Charities|Covid t9||||||||
|850k|||50,000|(46.500)|3,500||||3,500|
|NHS|Charities|Second||||||||
|wave|||50,000|(10.121)|39,880||(35,944)||3,936|
|NHS|Charities|Starbucks|2,100||2,100||||2,100|
|NHS|Chariiies|Stage 3||||58,041|(10,834)||47,207|
|hlHS|Charities|Stage 2||||474,723|(309.589)||165,134|
||||179,600|(83,918)|95,682|532,764|(390,422)||238,024|





## 

## 


## 

|Responder (|CFR)schem|es.||||||
|---|---|---|---|---|---|---|---|
|Analysis of|net assets|between funds||||||
|||Unrestricted|Restricted|Total|Unrestricted|Restdcted|Total|
|||funds|funds||funds|funds||
|||2022<br>f|2022|2022|2021f|2021|2021f|
|Fund balances at 31||||||||
|March 2022|are|||||||
|represented|by:|||||||
|Current assetsl||||||||
|(liabiiffies)||55,849|238,024|293,873|152,779|95,682|248,461|
|||55,849|238,024|293,873|152.779|95,682|248,46'I|





## 

## 

## 





## 

## 

|15|Cash generated<br>from operations|Cash generated<br>from operations|Cash generated<br>from operations|||2022|2021|
|---|---|---|---|---|---|---|---|
|||||||5||
||Surplus for|the year||||45,412|76,443|
||Adjustments|for:||||||
||investment|income recognised|in statement|offinancial|activities|(328)|(35)|
||Movements|in working capital:||||||
||increase<br>in|creditors||||286,279|23,825|
||Cash generated<br>from operations|||||331,363|100,233|